Position in EXEL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$34,337,986
+$9,301,207 QoQ
Shares Held
631,097
+8.1% QoQ
Ownership
0.255%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#61
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. EXEL ranks #18 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,337,986 | 631,097 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $25,036,779 | 583,744 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $25,202,512 | 575,006 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $24,625,000 | 596,247 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $27,329,731 | 620,003 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $23,932,208 | 648,218 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $22,059,118 | 662,436 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $17,276,004 | 665,742 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $21,856,343 | 972,690 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $27,198,305 | 1,146,157 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $27,635,016 | 1,151,939 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $25,925,287 | 1,186,512 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $23,587,892 | 1,234,322 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $24,923,914 | 1,284,076 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $20,422,400 | 1,273,217 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $19,691,335 | 1,255,825 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $26,480,228 | 1,271,865 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $24,386,231 | 1,075,705 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $19,845,608 | 1,085,646 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $23,152,950 | 1,095,220 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $19,991,584 | 1,097,233 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $24,331,756 | 1,077,103 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $18,572,777 | 925,400 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $22,560,650 | 922,726 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $22,543,195 | 949,587 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $16,027,876 | 930,771 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||